A clinical trial to study the effect of trial drug OMA LEGIUM (Internal) THAGARAI LEBAM(External)on Kalanjagapadai(Psoriasis)

An Open Clinical Study to evaluate the clinical efficacy of siddha sasthric formulation "OMA LEGIYAM"(Internal)"THAGARAI LEBAM" for the treatment of Kalanjagapadai.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012548

Enrollment

Registered

2018-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Itching silvery scaling

Interventions

Intervention1: Oma legium (Internal) Thagarai Lebam(External): Oma legium 1 Kazhanju(5.1gram)with milk Thagarai Lebam sufficient amount(External)for 48 days Control Intervention1: Not ApplicABLE: NOT

Eligibility

Inclusion criteria

Inclusion criteria: silvery scaly patches coin shaped lesion willing for admission and study in IPD 14 days or willing to OPD

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Hypertension Cardiac problems Use narcotic drugs Diabetes mellitus Tuberculosis Malignancy

Design outcomes

Primary

Measure	Time frame
Reduced Scalling and itchingTimepoint: 48 days	—

Secondary

Measure	Time frame
Evaluation of Siddha Diagnostic ParametersTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr T Murugavel

Government Siddha Medical College

dr.ahamed63@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026